Modular Medical Submits FDA Application for Pivot Pump Software Customization Upgrades
MODD•Modular Medical submitted FDA documentation for software enhancements to its Pivot tubeless insulin patch pump, featuring UI refinements and customizable patient settings. This marks the first planned upgrade phase after initial clearance and launch, with FDA feedback expected within weeks.
1. FDA Submission Details
Modular Medical filed a submission with the U.S. Food & Drug Administration outlining a series of software enhancements for its Pivot™ tubeless insulin patch pump. The package includes new customization settings for patient flexibility, user-interface refinements to streamline control, and other system software upgrades aimed at improving device performance.
2. Development Roadmap
This submission represents the initial phase of planned upgrades following FDA clearance of the Pivot’s core form factor and its entry into the commercial market. The company indicated these software enhancements will be followed by further improvements to expand functionality and user experience.
3. Anticipated FDA Review
Modular Medical expects to receive feedback from the FDA in the coming weeks, which will guide the timeline for deployment of the new features. Positive clearance will enable a software update rollout to current and future patients using the Pivot system.
